(Q46425557)

English

Long-term results of a multicenter randomized, comparative trial of modified CHOP versus THP-COP versus THP-COPE regimens in elderly patients with non-Hodgkin's lymphoma

scientific article published in April 2005

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15814336

Long-term results of a multicenter randomized, comparative trial of modified CHOP versus THP-COP versus THP-COPE regimens in elderly patients with non-Hodgkin's lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15814336

multicenter clinical trial

1 reference

based on heuristic

inferred from title

author name string

Mayumi Mori

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15814336

Kiyoshi Kitamura

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15814336

Michihiko Masuda

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15814336

Tomomitsu Hotta

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15814336

Tamotsu Miyazaki

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15814336

Akira B Miura

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15814336

Hideaki Mizoguchi

7

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15814336

Akira Shibata

8

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15814336

Hidehiko Saito

9

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15814336

Tamotsu Matsuda

10

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15814336

Toru Masaoka

11

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15814336

Mine Harada

12

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15814336

Yoshiyuki Niho

13

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15814336

Fumimaro Takaku

14

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15814336

publication date

1 April 2005

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15814336

International Journal of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15814336

81

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15814336

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15814336

246-254

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15814336

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elderly patients with non-Hodgkin's lymphoma: population-based results in The Netherlands

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical trials and drug toxicity in the elderly. The experience of the Eastern Cooperative Oncology Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology of non-Hodgkin's lymphoma: recent findings regarding an emerging epidemic.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Weekly administration of vincristine, cyclophosphamide, mitoxantrone and bleomycin (VEMB) in the treatment of elderly aggressive non Hodgkin's lymphoma. Gruppo Italiano per lo Studio dei Linfomi

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of age on the characteristics and clinical behavior of non-Hodgkin's lymphoma patients. The Non-Hodgkin's Lymphoma Classification Project

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The treatment of elderly patients with aggressive non-Hodgkin's lymphomas: feasibility and efficacy of an intensive multidrug regimen

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced-dose chop therapy for elderly patients with non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early assessment of a new anticancer drug analogue--are the historical comparisons obsolete? The French experience with pirarubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

THP-COPBLM (pirarubicin, cyclophosphamide, vincristine, prednisone, bleomycin and procarbazine) regimen combined with granulocyte colony-stimulating factor (G-CSF) for non-Hodgkin's lymphoma in elderly patients: a prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibody therapy for B-cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA).

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Full dose CHOP chemotherapy in elderly patients with non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I trial of standard and cyclophosphamide dose-escalated CHOP with granulocyte colony stimulating factor in elderly patients with non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The importance of dose intensity in the outcome of chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A combination of mitoxantrone, etoposide and prednisone in elderly patients with non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term results of treatment of patients with follicular lymphomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elderly aggressive-histology non-Hodgkin's lymphoma: first-line VNCOP-B regimen experience on 350 patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-Hodgkin's lymphoma in elderly patients: a phase II study of MCOP chemotherapy in patients aged 70 years or over with intermediate- or high-grade histology

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

P-VABEC: a prospective study of a new weekly chemotherapy regimen for elderly aggressive non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Continuous infusion of vincristine-doxorubicin with bolus of dexamethasone(VAD) alternated with CHEP in the treatment of patients over 60 years old with aggressive non-Hodgkin's lymphoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy for older patients with newly diagnosed, advanced-stage, aggressive-histology non-Hodgkin lymphoma: a systematic review

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aggressive Chemotherapy for Diffuse Histiocytic Lymphoma in the Elderly: Increased Complications with Advancing Age

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A brief-duration combination chemotherapy for elderly patients with poor-prognosis non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose ACOP-B and VABE: weekly chemotherapy for elderly patients with advanced-stage diffuse large-cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-Hodgkin's lymphoma. A four-drug regimen suitable for elderly patients with advanced disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of aggressive non-Hodgkin's lymphoma in elderly patients with thiotepa, Novantrone (mitoxantrone), vincristine, prednisone (TNOP).

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy plus granulocyte-macrophage colony-stimulating factor: identification of two age subgroups with differing hematologic toxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of dose intensity in determining outcome in intermediate-grade non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In search of an optimal regimen for elderly patients with advanced-stage diffuse large-cell lymphoma: results of a phase II study of P/DOCE chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CHOP with high dose cyclophosphamide consolidation versus CHOP alone as initial therapy for advanced stage, indolent non-Hodgkin's lymphomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomised multicentre trial of modified CHOP versus MCOP in patients aged 65 years and over with aggressive non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of granulocyte colony-stimulating factor administration in elderly patients with aggressive non-Hodgkin's lymphoma treated with a pirarubicin-combination chemotherapy regimen. Groupe d'Etudes des Lymphomes de l'Adulte.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolonged single-agent versus combination chemotherapy in indolent follicular lymphomas: a study of the cancer and leukemia group B.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBO.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II trial of prednisone, oral etoposide, and novantrone (PEN) as initial treatment of non-Hodgkin's lymphoma in elderly patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mitoxantrone, prednimustine, and vincristine for elderly patients with aggressive non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CHOP compared with CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination Chemotherapy Specifically Devised for Elderly Patients with Unfavorable Non-Hodgkin's Lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15814336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1532/IJH97.03147

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15814336

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15814336

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46425557&oldid=2207859202"